Rare carcinoma of pancreas

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

1 event
Sep 2016FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

National Cancer Institute (NCI) — PHASE2

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Rare carcinoma of pancreas.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Onivyde

(irinotecan liposome injection)Orphan drugstandard

Ipsen Biopharmaceuticals, Inc.

12.1 Mechanism of Action Irinotecan liposome injection is a topoisomerase 1 inhibitor encapsulated in a lipid bilayer vesicle or liposome. Topoisomera...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Rare carcinoma of pancreas.
Search all trials →
Search clinical trials for Rare carcinoma of pancreas

Recent News & Research

No recent news articles indexed yet for Rare carcinoma of pancreas.
Search PubMed for Rare carcinoma of pancreas

Browse all Rare carcinoma of pancreas news →

Specialist Network

Top 6 by expertise

View all Rare carcinoma of pancreas specialists →

Quick Actions